The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Correspondence
PreviousPrevious
Volume 360:2477-2479 June 4, 2009 Number 23
NextNext

C3 Polymorphisms and Outcomes of Renal Allografts

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF
-PDA Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited
-E-mail When Letters Appear

More Information
-Related Article
by Varagunam, M.
-PubMed Citation
To the Editor: Varagunam et al. (Feb. 26 issue)1 do not confirm the previously reported association between the complement component 3 (C3) SS genotype and worsened outcomes of renal transplantation.2 However, the disparity in the results of these two studies may be due to differences in the proportion of recipients with specific risks of chronic allograft dysfunction. Moreover, the C3 SS genotype can be either a protective factor1 or an exacerbating factor in the progression of endogenous kidney disease, and it varies according to the disorder. For example, the SS genotype is associated with accelerated progression of membranous nephropathy3 and . . . [Full Text of this Article]



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.